Mittendorf EA, Caudle AS, Yang W, et al. Implementation of the American College of Surgeons Oncology Group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014;21:2468–73.
Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy JAMA Oncol. 2017;3(4):549–55.
Mamtani A, Barrio AV, King TA, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? results of a prospective study. Ann Surg Oncol. 2016;23:3467–74.
Article PubMed PubMed Central Google Scholar
Al-Hilli Z, Hoskin TL, Day CN, et al. Impact of neoadjuvant chemotherapy on nodal disease and nodal surgery by tumor subtype. Ann Surg Oncol. 2018;25:482–93.
Nguyen TT, Hoskin TL, Day CN, et al. Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25:2596–602.
Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18. https://doi.org/10.1016/S1470-2045(13)70166-9.
Boughey JC, Suman VJ, Mittendorf EA, et al. Alliance for Clinical Trials in Oncology. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455-61. https://doi.org/10.1001/jama.2013.278932.
Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258–64.
Simons JM, van Nijnatten TJA, van Pol JJ, et al. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy for node- positive breast cancer A systematic review and meta-analysis. Ann Surg. 2019;269:432–42.
Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Feasibility trial for selective surgical localization of axillary lymph nodes containing metastases in breast cancer patients. JAMA Surg. 2015;150(2):137–43. https://doi.org/10.1001/jamasurg.2014.1086.
Article PubMed PubMed Central Google Scholar
Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection J Clin Oncol. 2016;34:1072–8.
Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy: Results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263:802–7.
Cabioglu N, Karanlık H, Kangal D, et al. Improved false negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25:3030–6.
Plecha D, Bai S, Patterson H, et al. Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes. Ann Surg Oncol. 2015;22:4241–6.
Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. EJSO. 2018;44:1307–11.
Balasubramian R, Morgan C, Shaari E, et al. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Eur J Surg Oncol. 2020;46:1028–33.
Kim WH, Kim HJ, Jung JH, et al. Ultrasound-guided restaging and localization of axillary lymph nodes after neoadjuvant chemotherapy for guidance of axillary surgery in breast cancer patients experience with activated charcoal. Ann Surg Oncol. 2018;25:494–500.
Natsiopoulos I, Intzes S, Liappis T, et al. Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment. Clin Breast Cancer. 2019;19(3):208–15.
Siso C, de Torres J, Colmenarejo AE, et al. Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA Trial). Ann Surg Oncol. 2018;25:784–91.
Moreno JLG, Gonzalez AMB, Góngora MA, et al. Targeted axillary dissection in breast cancer by marking lymph node metastasis with a magnetic seed before starting neoadjuvant treatment. Journal of Surgical Case Reports. 2019;11:1–3.
Ersoy YE, Kadioglu H, et al. Review of novel sentinel lymph node biopsy techniques in breast cancer patients treated with neoadjuvant chemotherapy. Clin Breast Cancer. 2018;18(4):e555–9.
Woods RW, Camp MS, Durr NJ, et al. A review of options for localization of axillary lymph nodes in the treatment of invasive breast Cancer. Acad Radiol. 2019;26(6):805–19.
Kuemmel S, Heil J, Rueland A, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg. 2020. https://doi.org/10.1097/SLA.0000000000004572.
Schwarnkar PK, Tayeh S, Michell MJ, Mokbel K. The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systemic review and pooled analysis. Cancers. 2021;13:1539.
Ahmed M, Douek M. Sentinel node and occult lesion localization (SNOLL): a systematic review. Breast. 2013;22(6):1034–40. https://doi.org/10.1016/j.breast.2013.09.007.
Article CAS PubMed Google Scholar
Erbil Y, Sari S, Ağcaoğlu O, et al. Radio-guided excision of metastatic lymph nodes in thyroid carcinoma: a safe technique for previously operated neck compartments. World J Surg. 2010;34(11):2581–8. https://doi.org/10.1007/s00268-010-0714-y.
Trinh L, Miyake KK, Dirbas FM, et al. CT-guided wire localization for involved axillary lymph nodes after neo-adjuvant chemotherapy in patients with initially node-positive breast cancer. Breast J. 2016;22(4):390–6. https://doi.org/10.1111/tbj.12597.
Hamdy O, El-Badrawy A, Saleh GA, et al. Preoperative localization of sentinel lymph node in breast cancer patients by silver wire insertion or liquid charcoal injection guided by CT lymphography. Breast Journal. 2020;26(4):617–24. https://doi.org/10.1111/tbj.13511.
Article CAS PubMed Google Scholar
Cho N, Moon WK, Han W, Park IA, Cho J, Noh DY. Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results. AJR Am J Roentgenol. 2009;193(6):1731–7.
Bedi DG, Krishnamurthy R, Krishnamurthy S, et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008;191(3):646–52.
Chang JM, Leung JWT, Moy L, Ha SM, Moon WK. Axillary Nodal Evaluation in Breast Cancer: State of the Art. Radiology. 2020;295(3):500–15.
Ozkurt E, Yardımcı E, Tükenmez M, et al. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer. Breast J. 2019;25(1):96–102. https://doi.org/10.1111/tbj.13149.
Ozmen V, Unal ES, Muslumanoglu ME, et al. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol. 2010;36:23–9.
Article CAS PubMed Google Scholar
Mazouni C, Peintinger F, Wan-Kau S, et al. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. J Clin Oncol. 2007;25:2650–5.
Comments (0)